Oorsprong van het eerstegraads netwerk van Jennifer Shea
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Other | 27 | |
Bioniche Pharma Group Ltd.
 Bioniche Pharma Group Ltd. Medical SpecialtiesHealth Technology Bioniche Pharma Group Ltd. is a specialty pharmaceutical company involved primarily in the development, manufacturing, and marketing of sterile injectable products. The company sells a number of non-branded products in the U.S. market for which it has received approved Abbreviated New Drug Applications. It also sells its branded product Suplasyn in 30 countries globally. The firm's products are sold to both the primary care and hospital markets in the U.S., Canada, and Europe. The company was founded in 2000 and is headquartered in Casla, Ireland.
6
| Subsidiary | Medical Specialties | 6 |
NovaVive, Inc.
 NovaVive, Inc. BiotechnologyHealth Technology NovaVive, Inc. provides biotechnology services. The company was founded in 2014 and is headquartered in Belleville, Canada.
3
| Private Company | Biotechnology | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jennifer Shea via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BAXTER INTERNATIONAL INC. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| MICROBIX BIOSYSTEMS INC. | Biotechnology | Chief Executive Officer | |
| HELIX BIOPHARMA CORP. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| ACASTI PHARMA INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Aerami Therapeutics Holdings, Inc.
 Aerami Therapeutics Holdings, Inc. Medical SpecialtiesHealth Technology Dance Biopharm Holdings, Inc. engages in providing health care services. The company was founded by John Stuart Patton in 2010 and is headquartered in San Francisco, CA. | Medical Specialties | Director/Board Member | |
Centre Hospitalier de l'Universite de Montreal
 Centre Hospitalier de l'Universite de Montreal Hospital/Nursing ManagementHealth Services Centre Hospitalier de lUniversite de Montreal owns and operates general hospitals. The firm provides inpatient and ambulatory care to its immediate urban clientele and specialized & ultra specialized services. The company was founded in 1995 and is headquartered in Montreal, Canada. | Hospital/Nursing Management | Corporate Officer/Principal | |
National Bank Financial, Inc. (Broker)
 National Bank Financial, Inc. (Broker) Investment Banks/BrokersFinance National Bank Financial, Inc. (Broker) (NBF-Broker) is the broker/dealer division of National Bank Financial, Inc., a Canadian mutual fund manager headquartered in Montréal, Quebec. The firm was founded in 1902 and is a direct subsidiary of National Bank Acquisition Holding, Inc., ultimately owned by National Bank of Canada (TSX: NA). NBF-Broker provides retail advisory and brokerage services with institutional brokerage, investment banking, corporate finance and securities clearing services for third parties. The firm has a substantial presence in all regions of Canada, as well as operations in the US and Europe. | Investment Banks/Brokers | Analyst-Equity | |
Trillium Health Care Products, Inc.
 Trillium Health Care Products, Inc. Pharmaceuticals: MajorHealth Technology Trillium Health Care Products, Inc. manufactures pharmaceutical and health care products. The firm offers over-the-counter and prescription pharmaceutical products in solid, semi-solid, and liquid dosage forms for market segments, including pain and inflammation, gastro-intestinal, cold and flu, allergy, dermatology, oral care, and nutrition. The company was founded in 1993 and is headquartered in Brockville, Canada. | Pharmaceuticals: Major | Chairman | |
| McGill University | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree Doctorate Degree | |
Excelsior Medical Corp.
 Excelsior Medical Corp. Medical SpecialtiesHealth Technology Excelsior Medical Corp. manufactures medical flush syringes and syringe pump systems. The firm products includes saline and heparin flush syringes, dispensing pumps, syringe pumps, and SwabCap. The company was founded in 1989 and is headquartered in Neptune, NJ. | Medical Specialties | Director/Board Member Chairman Chief Executive Officer | |
| Concordia University | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| University of British Columbia | College/University | Undergraduate Degree Doctorate Degree | |
| University of Guelph | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Lancaster | College/University | Undergraduate Degree | |
| University of Montréal | College/University | Doctorate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
PainCeptor Pharma Corp.
 PainCeptor Pharma Corp. Pharmaceuticals: MajorHealth Technology PainCeptor Pharma Corp. operates as a biopharmaceutical company which engages in the development of pharmaceuticals for chronic and acute pain. It offers next generation therapeutic drugs for the treatment of chronic and acute pain. The firms products includes NGF/p75-TrkA, ASIC1a and ASIC3. The company was founded by Louis Lamontagne in 2003 and is headquartered in St-Laurent, Canada. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Aegera Therapeutics, Inc.
 Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Biotechnology | Chief Executive Officer Chairman President Corporate Officer/Principal | |
Roundtable Healthcare Management, Inc.
 Roundtable Healthcare Management, Inc. Investment ManagersFinance Roundtable Healthcare Management, Inc (Roundtable Healthcare Management) is an Independent Private Equity firm founded in 2001 by Todd Warnock, Joseph Damico, Lester Knight and Jack McGinley. The firm is headquartered in Lake Forest, Illinois, United States. | Investment Managers | Founder Founder | |
Pacira Pharmaceuticals, Inc. (California)
 Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Pacira Pharmaceuticals, Inc. develops and manufactures injectable and sustained release therapeutic products. It focuses on clinical and commercial development activities by understanding the needs of the acute care market. The company was founded in March 2007 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member | |
DSM Biologics Holding, Inc.
 DSM Biologics Holding, Inc. BiotechnologyHealth Technology Part of DSM-Firmenich AG, DSM Biologics Holding, Inc. is a Canadian company that manufactures biological and pharmaceutical products. The private company is based in Montréal, Canada. The company was founded by Jos van Weperen. DSM Biologics Holding was acquired by DSM Pharmaceuticals, Inc., a subsidiary of DSM-Firmenich AG from Province of Québec on July 13, 2005. | Biotechnology | Director of Finance/CFO | |
| AVIVAGEN INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Viron Therapeutics, Inc.
 Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | Pharmaceuticals: Major | President Chief Executive Officer | |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Chairman | |
| IMMUNOTEC INC. | Other Consumer Services | Chief Executive Officer Chairman | |
Oxfam International
 Oxfam International Miscellaneous Commercial ServicesCommercial Services Oxfam International operates charitable organizations. The non-profit company is based in Oxford, UK. | Miscellaneous Commercial Services | Director/Board Member | |
BioQuebec
 BioQuebec BiotechnologyHealth Technology BioQuebec is the largest biotechnology and life sciences network in Quebec, Canada. The private company is based in Bromont, Canada. BioQuebec's 130 members include companies and organizations that operate at every level of the biotechnology and life sciences innovation chain, ranging from biotechs to pharmas, contract research organizations, venture capital firms, and support organizations. The Canadian company engages in governmental representation, business development, and partnerships to support the growth of Quebec's biotechnology and life sciences industry, which creates wealth and specialized jobs, is focused on innovation and marketing, and is dedicated to improving everyone's health and quality of life. BioQuebec's actions aim to make Quebec one of the industry's most significant and valuable players on the international stage. The company was founded in 1991 by Pierre Alary, and the CEO is Mario Lebrun. | Biotechnology | Chairman | |
| Sir George Williams University | College/University | Masters Business Admin | |
| Hoechst Marion Roussel Canada, Inc. | Chief Tech/Sci/R&D Officer | ||
| IQVIA RDS Canada ULC | Corporate Officer/Principal | ||
| Berlex Canada, Inc. | Chief Tech/Sci/R&D Officer | ||
Canadian Animal Health Institute
 Canadian Animal Health Institute Pharmaceuticals: MajorHealth Technology Canadian Animal Health Institute operates as the trade association representing the developers, manufacturers and distributors of animal pharmaceuticals, biologics, feed additives and animal pesticides. The firm serves in the animal health product market. The company is headquartered in Guelph, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Québec Biotechnology Innovation Centre
 Québec Biotechnology Innovation Centre BiotechnologyHealth Technology Québec Biotechnology Innovation Centre operates research and development center for biotechnology. It offers infrastructure, consulting, and funding services. The company was founded in 1995 and is headquartered in Laval, Canada. | Biotechnology | Chairman | |
Tower Holdings, Inc. (New Jersey)
 Tower Holdings, Inc. (New Jersey) Pharmaceuticals: MajorHealth Technology Tower Holdings, Inc. operates as a holding company. The company is headquartered in Middlesex, NJ. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Montreal Invivo Organization | Director/Board Member | ||
Aerami Therapeutics, Inc.
 Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member | |
SOTA Orthopaedics Ltd.
 SOTA Orthopaedics Ltd. Medical SpecialtiesHealth Technology SOTA Orthopaedics Ltd. manufactures and distributes orthopedic devices. Its products include IM Hip Nailing, Dynamic Plating and Mini Plate. The firm provides an expanding bolt medical device used to repair hip fractures. It operates through its locations in Bristol and Dublin. The company was founded by Brian Thornes in 2007 and is headquartered in Dublin, Ireland. | Medical Specialties | Chairman | |
| HLS THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Oligo Medic, Inc. | Director/Board Member | ||
| AGRINAM ACQUISITION CORPORATION | Financial Conglomerates | Director/Board Member | |
Response Pharmaceuticals, Inc.
 Response Pharmaceuticals, Inc. BiotechnologyHealth Technology Response Pharmaceuticals, Inc. is a clinical-stage therapeutic development company that focuses on developing treatments for weight management and metabolic disease. The company is based in Falls Church, VA. The company's initial clinical focus is to help people taking antipsychotic medications for disabling mental illness combat weight gain and metabolic dysregulation that is endemic with these treatments. Response is developing RDX-002 as an adjunctive therapy for patients taking first-line antipsychotic therapy. The company was founded by Eric Keller, Paul Sweetnam. Eric Keller has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
St. Bernard Soap Co.
 St. Bernard Soap Co. Household/Personal CareConsumer Non-Durables Part of Trillium Health Care Products, Inc., St. Bernard Soap Co. is a company that manufactures and sells bar soaps. The company is based in Cincinnati, OH. | Household/Personal Care | Chairman |
Statistieken
Internationaal
| Canada | 32 |
| Verenigde Staten | 16 |
| Verenigd Koninkrijk | 4 |
| Ierland | 2 |
Sectoraal
| Health Technology | 31 |
| Consumer Services | 9 |
| Finance | 4 |
| Consumer Non-Durables | 3 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 100 |
| Chairman | 44 |
| Corporate Officer/Principal | 41 |
| Independent Dir/Board Member | 28 |
| Chief Executive Officer | 24 |
Sterkste connecties
| Insiders | |
|---|---|
| Joseph F. Damico | 29 |
| Michael Berendt | 20 |
| Donald Olds | 20 |
| Lorne Babiuk | 18 |
| James Moodie Rae | 12 |
| Steven T. Thornton | 12 |
| Gregory Gubitz | 12 |
| Albert Beraldo | 11 |
| Yvon Bastien | 11 |
| François Charette | 9 |
| Jack McGinley | 9 |
| Lyne Fortin | 9 |
| Nick Photiades | 9 |
| Rod Budd | 7 |
| Cameron Groome | 7 |
- Beurs
- Insiders
- Jennifer Shea
- Bedrijfsconnecties
